During the past decade, Hospital Universitari de Girona Dr Josep Trueta; Departamento de Oncologia Medica conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Hospital Universitari de Girona Dr Josep Trueta; Departamento de Oncologia Medica" are "Carcinoma, Non-Small-Cell Lung" (1 trials), "Non-Small Cell Lung Cancer" (1 trials) and "Non-Small Cell Lung Cancer (NSCLC)" (1 trials). Many other conditions were trialed in "Hospital Universitari de Girona Dr Josep Trueta; Departamento de Oncologia Medica" in a lesser frequency.

Most popular intervention types in "Hospital Universitari de Girona Dr Josep Trueta; Departamento de Oncologia Medica" are "Drug" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (2 trials), "Actigraphy device (wearable) and mobile application" (1 trials), "Carboplatin" (1 trials), "Cisplatin" (1 trials) and "Pemetrexed" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Universitari de Girona Dr Josep Trueta; Departamento de Oncologia Medica" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Hospital Universitari de Girona Dr Josep Trueta; Departamento de Oncologia Medica". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Hospital Universitari de Girona Dr Josep Trueta; Departamento de Oncologia Medica, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Universitari de Girona Dr Josep Trueta; Departamento de Oncologia Medica, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".